These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6716272)

  • 1. Comparison of diazepam and oxazepam: preference, liking and extent of abuse.
    Griffiths RR; McLeod DR; Bigelow GE; Liebson IA; Roache JD; Nowowieski P
    J Pharmacol Exp Ther; 1984 May; 229(2):501-8. PubMed ID: 6716272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.
    Griffiths RR; Bigelow GE; Liebson I; Kaliszak JE
    J Pharmacol Exp Ther; 1980 Dec; 215(3):649-61. PubMed ID: 7441524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.
    Griffiths RR; McLeod DR; Bigelow GE; Liebson IA; Roache JD
    Psychopharmacology (Berl); 1984; 84(2):147-54. PubMed ID: 6438672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability.
    Roache JD; Griffiths RR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):978-88. PubMed ID: 3694540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
    Mumford GK; Rush CR; Griffiths RR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.
    Roache JD; Griffiths RR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):120-33. PubMed ID: 2861282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinforcing and subjective effects of the volatile anesthetic, sevoflurane.
    Walker DJ; Beckman NJ; Zacny JP
    Drug Alcohol Depend; 2004 Nov; 76(2):191-201. PubMed ID: 15488343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse liability of diazepam through different routes.
    Singh RK; Jain R; Ray R; Gupta YK
    Indian J Physiol Pharmacol; 2001 Apr; 45(2):181-90. PubMed ID: 11480224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug preferences in humans.
    Johanson CE; Uhlenhuth EH
    Fed Proc; 1982 Feb; 41(2):228-33. PubMed ID: 7060750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
    Jones HE; Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preference for alprazolam as opposed to diazepam in benzodiazepine-dependent psychiatric inpatients.
    Apelt S; Schmauss C; Emrich HM
    Pharmacopsychiatry; 1990 Mar; 23(2):70-5. PubMed ID: 1971118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human coffee drinking: reinforcing and physical dependence producing effects of caffeine.
    Griffiths RR; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1986 Nov; 239(2):416-25. PubMed ID: 3772801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the abuse potential of pagoclone, a partial GABAA agonist.
    de Wit H; Vicini L; Haig GM; Hunt T; Feltner D
    J Clin Psychopharmacol; 2006 Jun; 26(3):268-73. PubMed ID: 16702891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice.
    Troisi 2nd JR; Critchfield TS; Griffiths RR
    Behav Pharmacol; 1993 Jun; 4(3):217-230. PubMed ID: 11224189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preference for diazepam in anxious adults.
    McCracken SG; de Wit H; Uhlenhuth EH; Johanson CE
    J Clin Psychopharmacol; 1990 Jun; 10(3):190-6. PubMed ID: 2198297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam absorption kinetics affects abuse liability.
    Mumford GK; Evans SM; Fleishaker JC; Griffiths RR
    Clin Pharmacol Ther; 1995 Mar; 57(3):356-65. PubMed ID: 7697954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of the active metabolites to the tolerance developing to diazepam in man: relationship to bioassayed serum benzodiazepine levels.
    Aranko K; Mattila MJ; Seppälä T; Aranko S
    Med Biol; 1984; 62(5):277-84. PubMed ID: 6442383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.